BI Weekend: China Boeing Halt, LVMH Earnings
Bloomberg Intelligence
Navigating Setbacks: Pfizer and Boeing
This chapter explores Pfizer's decision to halt its obesity drug development due to safety concerns, examining the competitive landscape and potential strategies for growth, including acquisitions. It also analyzes Boeing's challenges in the Chinese market amid trade tensions, assessing the long-term implications for aircraft deliveries and the company's operations. The chapter emphasizes the importance of strategic moves for both Pfizer and Boeing as they adapt to evolving market conditions.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
